WHI Ca + D trial postmenopausal women with low BD 8.4% ± 10.2%US
RCT
I and C, respectively: 61.8 y, 62.0 y
Daily supplementation of 1,000 mg of Ca and 400 IU of vitamin D 1 y
122-item FFQ
PBD: mammogram: computer-assisted method
Null
Subgroup analyses: age, race/ethnicity, total vitamin D, HT treatment, Gail risk score, BMI, region of residence, category of mammogram density at baseline.
Premenopausal at entry and postmenopausal at followup Total: Canada
RCT
I and C, respectively: 49.5 y, 49.2 y.
Low-fat, high CHO intervention versus control 2 y
3 food records
ADT, PBD at baseline and 2 years mammogram: automated
Total fat (median change: 57–31 g/d) was associated with an average 5.61 cm2↓ in the ADT. Saturated fat (median change: 21–11 g/d) and was associated with an average 5.54 cm2↓ in the ADT and a 3.93% ↓ in PBD. Dietary cholesterol (median change: 229–150 mg/d) was associated in an average 3.27 cm2↓ in the ADT and a 3.52% ↓ in PBD.
Total energy, weight change (included in all models); age, family hx, smoking status, parity, ever breast feeding, OC use, age at menarche, age at first birth, PA
% body fat, age at randomization, age at visit, clinic, BMI- score, race, education, smoking status, PA at 14–17 years old and separately during the past year, number of full term pregnancies, hormonal contraceptives